Z 338: Clinical Trials

4 trials of Z 338, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Not yet recruiting 1

Follow Z 338: new trials by email Literature Review of Z 338 trials Research Report on Z 338

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Acotiamide vs Itopride in Postprandial Distress Syndrome
Acotiamide - Postprandial Distress Syndrome
Phase 3Not yet recruitingGetz Pharma1522025-10-302025-09-23
Phase III, Long-term, Open-label Safety Study of Z-338
Z-338 - Dyspepsia
Phase 3CompletedZeria Pharmaceutical2072014-03-012017-06-28
To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia
Z-338, Placebo - Functional Dyspepsia
Phase 3CompletedZeria Pharmaceutical8202008-09-012010-11-23
A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia
YM443 - Dyspepsia, Functional Dyspepsia
Phase 3CompletedAstellas Pharma Inc4122008-08-012014-10-29

Conditions studied

Dyspepsia (2)  ·  Signs and Symptoms, Digestive (1)

Sponsors

Zeria Pharmaceutical (2)  ·  Astellas Pharma Inc (1)  ·  Getz Pharma (1)

Countries

Japan (2)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Latvia (1)  ·  Lithuania (1)  ·  Romania (1)  ·  Russia (1)  ·  Slovakia (1)  ·  Sweden (1)  ·  Ukraine (1)  ·  United Kingdom (1)

Top investigators

Jan Tack, MD, PhD (1)  ·  Michio Hongo, Professor (1)  ·  Prof. Dr. Muahmmad Umar, MBBS, FCPS, FACG, AGAF, FRCP (1)

Results publications

PMID 22157329, PMID 29315999